Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood

European Journal of Pediatrics, Supplement

Volumn 158, Issue 3, 1999, Pages

  Ehrenforth, S ^b   Kreuz, W ^c   Scharrer, I ^c   Junker, R ^a   Koch, H G ^a   Nowak Gottl U ^a   Munchow N ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c NONE

Author keywords

Antithrombin; Childhood venous thrombosis; FV G1691A mutation; Lipoprotein (a); Protein C; Protein S

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; GLYCOPROTEIN; HEPARIN COFACTOR II; HOMOCYSTEINE; LIPOPROTEIN A; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HETEROZYGOTE; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; AGE OF ONSET; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; LIPOPROTEIN(A); MALE; MULTIFACTORIAL INHERITANCE; PREVALENCE; PROTEIN C; PROTEIN S; RISK FACTORS; STATISTICS, NONPARAMETRIC; THROMBOPHILIA;

EID: 0342288644     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Andrew M (1995) Developmental hemostasis: Relevance to thromboembolic complications in pediatric patients. Thromb Haemost 74:415-425
2. Andrew M, Paes B, Milner R, Johnston M, Powers P, Tollefsen DM (1987) The development of the human coagulation system in the fullterm infant. Blood 70:165-172
3. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998-2005
4. Araki A, Sako Y (1987) Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52
5. Ashka I, Aumann V, Bergmann F, Budde U, Eberl W, Eckhof-Donovan S, Krey S, Nowak-Göttl U, Schobeß R, Sutor AH, Wendisch J, Schneppenheim R (1996) Prevalence of factor V Leiden in children with thrombembolism. Eur J Pediatr 155:1009-1014
6. Bertina RM, Linden van der IK, Engesser L, Muller HP, Brommer EJP (1987) Hereditary heparin Cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost 57:196-200
7. Bick RL, Jakway J, Baker WF (1992) Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Sem Thromb Haemost 1:267-274
8. Castaman G, Ruggeri M, Burei F, Rodeghiero F (1993) High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families. Thromb Res 69:297-305
9. Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CRM (1997) The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol 98:353-355
10. Ehrenforth S, Aygören-Pürsün E, Hach-Wunderle V, Scharrer I (1994) Prevalence of elevated histidine-rich glycoprotein in patients with thrombophilia - a study of 695 patients. Thromb Haemost 71:160-161
11. Engesser L, Brommer EJP, Kluft C, Briet E (1989) Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic thrombophilia. Thromb Haemost 62:673-680
12. Engesser L, Kluft C, Briet E, Brommer EJP (1987) Familial elevation of plasma histidine-rich glycoprotein in a family with thrombophilia. Br J Haematol 67:355-358
13. Falkon L, Gari M, Montserrat I, Muniz E, Borell M, Fontcuberta J (1992) Familial elevation of plasma histidine-rich glycoprotein: a case associated with recurrent venous thrombosis and high PAI-1 levels. Thromb Res 66:265-270
14. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18-22
15. Hach-Wunderle V, Scharrer I, Lottenberg R (1988) Congenital deficiency of plasminogen and its relationship to venous thrombosis. Thromb Haemost 59:277-280
16. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M (1992) The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from venous and/or arterial thromboembolism. Thromb Haemost 68:285-290
17. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia (1995) Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 73:151-161
18. Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate LW (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Med 323:1512-1516
19. Jürgens G, Költringer P (1987) Lipoprotein (a) in ischemic cerebrovascular disease: A new approach to the assessment of risk for stroke. Neurology 37:513-515
20. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 345:152-155
21. Koster T, Rosendaal FR, Briet E, Vandenbroucke JP (1994) John Hagemann's factor and deep vein thrombosis: Leiden Thrombophilia Study. Br J Haematol 87:422-424
22. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-1506
23. Kraft HG, Lingenhel A, Bader G, Kostner GM, Utermann G (1996) The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 125:53-61
24. Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, Olsson T (1997) Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 28:1702-1709
25. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U (1996) Inherited thrombophilia: Part 1. Thromb Haemost 76:651-662
26. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U (1996) Inherited thrombophilia: Part 2. Thromb Haemost 76:824-834
27. Malm J, Laurell M, Nilsson IM, Dahlbäck B (1992) Thromboembolic disease. Critical evaluation of laboratory investigation. Thromb Haemost 68:7-13
28. Manco-Johnson MJ, Abshire TC, Jacobson LJ, Marlar RA (1991) Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatrics 119:793-798
29. Marcovina SM, Hobbs HH, Albers JJ (1996) Relation between number of apolipoprotein (a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem 42:436-439
30. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J, and the EMET group (1997) Laboratory evaluation and clinical characteristics of 2.132 consecutive unselected patients with venous thromboembolism - results of the Spanish multicentric study on thrombophilia (EMET-Study). Thromb Haemost 77:444-451
31. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 300:132-137
32. Meer van der FJM, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR (1997) The Leiden Thrombophilia study (LETS). Thromb Haemost 78:631-635
33. Melissari E, Monte G, Lindo VS, Pemberton KD, Wilson NV, Edmondson R, Das S, Kakkar VV (1992) Congenital thrombophilia among patients with venous thromboembolism. Blood Coagulation & Fibrinolysis 3:749-758
34. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG (1993) Inherited predisposition to thrombosis. Cell 72:477-480
35. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Audria G, Boers GHJ, Homberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L (1985) The natural history of homocystinuria due to cystathionine-β-synthase deficiency. Am J Hum Genet 37:1-31
36. Nowak-Göttl U, Debus O, Findeisen M, Kassenböhmer R, Koch HG, Pollmann H, Postler C, Weber P, Vielhaber H (1997) Lipoprotein (a): its role in childhood thrombo-embolism. Pediatrics (electronic pages) 99/6e11
37. Nowak-Göttl U, Dübbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J, Vielhaber H (1997) Factor V Leiden, protein C and lipoprotein (a) in catheter related thrombosis in childhood - a prospective study. J Pediatr 131:608-612
38. Nowak-Göttl U, Funk M, Mosch G, Wegerich B, Kornhuber B, Breddin HK (1994) Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and a2-antiplasmin in children using the new automated coagulation laboratory (ACL) method. Klin Pädiatr 206:437-439
39. Nowak-Göttl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszuk-Raschke K, Kehl HG, Jürgens H, Schneppenheim R (1996) Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Brit J Haematol 92:992-996
40. Nowak-Göttl U, Kohlhase B, Vielhaber H, Aschka I, Schneppenheim R, Jürgens H (1996) APC Resistance in neonates and infants: adjustment of the aPTT-based method. Thromb Res 81:665-670
41. Nowak-Göttl U, Kries von R, Göbel U (1997) Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child 76:F163-167
42. Nowak-Göttl U, Sträter R, Dübbers A, Oleszuk-Raschke K, Vielhaber H (1996) Ischaemic stroke in infancy and childhood: role of the Arg 506 to Gln mutation in the factor V gene. Blood Coagulation & Fibrinolysis 7:684-688
43. Nuss R, Hys T, Manco-Johnson M (1995) Childhood thrombosis. Pediatrics 96:291-294
44. Pabinger I, Brückner S, Kyrle PA, Schneider B, Korninger HC, Niessner H, Lechner K (1992) Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinol 3:547-553
45. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3003
46. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (Activated protein C resistance). Blood 85:1504-1508
47. Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A (1994) Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds. Blood Coag Fibrinol 5:889-893
48. Seligsohn U, Zivelin A (1997) Thrombophilia as a multigenetic disorder. Thromb Haemost 78(1):297-301
49. Seriolo B, Accardo S, Fasciolo D, Bertolini S, Cutolo M (1996) Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis. Clin Exp Rheumatol 14:593-599
50. Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson MJ (1996) Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr 128:324-328
51. Stefano de V, Finazzi G, Mannucci PM (1996) Inherited thrombophilia: Pathogenesis, clinical syndromes and management. Blood 87:3531-3544
52. Taberno MD, Tomas JF, Alberca I, Orfao A, Lopez-Borrasca A, Vicente V (1991) Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 36:249-254